MOH Assures MyUBAT App Can Verify All Drug Holograms, System Remains Secure
PUTRAJAYA: The Ministry of Health Malaysia has dismissed concerns over a possible failure in the verification system for pharmaceutical hologram labels, affirming that current safeguards remain reliable in protecting consumers from counterfeit or unregistered products.
The ministry said the hologram verification framework, overseen by the Drug Control Authority, continues to function effectively as part of Malaysia’s broader regulatory system for health products.
The ministry said these mechanisms are designed to ensure compliance with strict safety and quality standards, reducing the risk of counterfeit or substandard products entering the market.
As part of ongoing digitalisation efforts, MOH highlighted improvements to the MyUBAT application, which now serves as a unified platform for verifying the authenticity of pharmaceutical safety labels.
According to the ministry, the upgraded application is capable of scanning and validating all versions of MOH hologram labels, including both older and newly issued designs.
“This ensures that consumers and healthcare providers can continue to verify product authenticity regardless of the label version used,” the statement said.
In addition to the app-based system, MOH noted that verification can also be carried out at licensed pharmacies equipped with approved authentication devices, offering an additional layer of assurance for the public.
The ministry reiterated its firm stance against the distribution of unregistered or counterfeit health products, warning that strict enforcement action will be taken against those found violating regulations, including individuals or entities involved in falsifying safety labels.
MOH also urged consumers to remain vigilant by purchasing medicines only from authorised outlets and making use of available verification tools such as the MyUBAT app.
Members of the public are encouraged to report suspicious products or irregularities to the authorities promptly, as part of a collective effort to maintain the integrity of Malaysia’s healthcare supply chain.
The reassurance comes amid heightened public concern over drug safety, with the ministry emphasising that technological enhancements and regulatory oversight will continue to be strengthened to safeguard public health.
-wilayah.com.my
